Intravitreal ranibizumab injection for neovascular age-related macular degeneration in phakic versus pseudophakic eyes

Retina

Volumn 33, Issue 3, 2013, Pages 467-473

  Sun Baek, Ji ^a   Cho, Han Joo ^a   Cho, Sung Won ^a   Kim, Chul Gu ^a   Kim, Jong Woo ^a  

^a Konyang University College of Medicine   (South Korea)

Author keywords

age related macular degeneration; pseudophakia; ranibizumab

Indexed keywords

RANIBIZUMAB;

AGED; APHAKIA; ARTICLE; BEST CORRECTED VISUAL ACUITY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EXUDATIVE MACULAR DEGENERATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OPTICAL COHERENCE TOMOGRAPHY; PSEUDOPHAKIA; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA LUTEA; RETINAL THICKNESS; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; COLORING AGENTS; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INDOCYANINE GREEN; INTRAVITREAL INJECTIONS; LENS, CRYSTALLINE; MALE; MIDDLE AGED; PSEUDOPHAKIA; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 84874946246     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3182753b2a     Document Type: Article

References (27)

1. Bressler NM, Bressler SB, Congdon NG, et al Age-Related Eye Disease Study Research Group. Potential public health impact of age-related eye disease study results: AREDS report no.11. Arch Ophthalmol 2003;121:1621-1624
2. Brown NM, Brown GC, Sharma S, et al. The burden of agerelated macular degeneration: A value based analysis. Curr Opin Ophthalmol 2006;17:257-266
3. Adamis AP, Shima DT. The role of vascular endothelial growth factor in the ocular health and disease. Retina 2005; 25:111-118
4. Schlingemann RO. Role of growth factors and the wound healing response in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2004;242:91-101
5. Holekamp NM, Bouck N, Volpert O. Pigment epithelium derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration. Am J Ophthalmol 2002;134:220-227
6. Otani A, Takagi H, Oh H, Koyama S, et al. Expression of angiopoietins and Tie2 in human choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1999;40:1912-1920
7. Kliffen M, Sharma HS, Mooy CM, et al. Increased expression of angiogenic growth factors in age related maculopathy. Br J Ophthalmol 1997;81:154-162
8. Rosenfeld PJ, Brown DM, Heier JS, et al MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-1431
9. Kaiser PK, Blodi BA, Shapiro H, et al MARINA Study Group. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology 2007;114:1868-1875
10. Wang JJ, Klein R, Smith W, et al. Cataract surgery and the 5-year incidence of late-stage age-related maculopathy: Pooled findings from the Beaver Dam and Blue Mountains eye studies. Ophthalmology 2003;110:1960-1967
11. Armbrecht AM, Findlay C, Aspinall PA, et al. Cataract surgery in patients with age-related macular degeneration: One year outcomes. J Cataract Refract Surg 2003;29:686-693
12. Pollack A, Bukelman A, Zalish M, et al. The course of agerelated macular degeneration following bilateral cataract surgery. Ophthalmic Surg Lasers 1998;29:286-294
13. Pollack A, Mareovich A, Bukelman A, et al. Age-related macular degeneration after extracapsular cataract extraction with intraocular lens implantation. Ophthalmology 1996;103: 1546-1554
14. Bettelheim FA, Zigler JS. Regional mapping of molecular components of human liquid vitreous by dynamic light scattering. Exp Eye Res 2004;79:713-718
15. Neal RE, Bettelheim FA, Lin C, et al. Alterations in human vitreous humour following cataract extraction. Exp Eye Res 2005;80:337-347
16. Hilford D, Hilford M, Mathew A, Polkinghorne PJ. Posterior vitreous detachment following cataract surgery. Eye (Lond) 2009;23:1388-1392
17. Goldenberg DT, Giblin FJ, Cheng M, et al. Posterior vitreous detachment with microplasmin alters the retinal penetration of intravitreal bevacizumab in rabbit eyes. Retina 2011;31: 393-400
18. Corwin JM, Weiter JJ. Immunology of chorioretinal disorders. Surv Ophthalmol 1981;25:287-305
19. Hykin PG, Gregson RM, Stevens JD, Hamilton PA. Extracapsular cataract extraction in proliferative diabetic retinopathy. Ophthalmology 1993;100:394-399
20. Mirshahi A, Hoehn F, Lorenz K, Hattenbach LO. Incidence of posterior vitreous detachment after cataract surgery. J Cataract Refract Surg 2009;35:987-991
21. Hikichi T. Time course of Development of posterior vitreous detachments after phacoemulsification surgery. Ophthalmology 2012;119:2102-2107
22. Goldenberg DT, Trese MT. Pharmacologic vitreodynamics; what is it? Why is it important? Expert Rev Ophthalmol 2008;3:273-277
23. Wilkinson CP, Rice TA. Michels Retinal Detachment. 2nd ed. St Louis, MO: Mosby; 1997:9-17
24. Stefansson E. Physiology of vitreous surgery. Graefes Arch Clin Exp Ophthalmol 2005;123:209-213
25. Peters S, Heiduschka P, Julien S, et al. Immunohistochemical localization of intravitreally injected bevacizumab in the anterior chamber angle, iris, and ciliary body of the primate eye. Br J Ophthalmol 2008;92:541-544
26. Gaudreault J, Fei D, Beyer JC, et al. Pharmacokinetics and retinal distribution of Ranibizumab, a humanized antibody fragment directed against VEGF-A, following intravitreal administration in rabbits. Retina 2007;27:1260-1266
27. Lee SS, Ghosn C, Yu Z, et al. Vitreous VEGF clearance is increased after vitrectomy. Invest Ophthalmol Vis Sci 2010;51: 2135-2138